drugset / Trial / NCT00484393

Tetracaine Compared to Placebo for Reducing Pain With Palivizumab - A Pilot Study

NCT00484393

Phase 4 Completed 7 enrolled Fraser Health
RandomizedCrossoverTriple-blindSupportive care

Summary

This is a small study known as a pilot study. This pilot study is being done to see if a difference in pain from intramuscular palivizumab injection can be detected if tetracaine a topical numbing gel is used compared to no medication (placebo). If a difference is found in this pilot study, then a larger study may be done to confirm that there is a difference in pain experience.

Timeline

Start
2007-11
Primary completion
2008-04
Completion
2008-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject tetracaine Other / unclassified 1 g Topical

Indications

No indication recorded.